For market participants researching Iteris stock, one crucial reality must be understood: the company’s public trading status concluded over a year ago. Iteris was officially delisted from the NASDAQ on November 1, 2024, following its acquisition by the Italian firm Almaviva S.p.A.
The Final Transaction
The path to delisting was set in motion on August 9, 2024, when Almaviva publicly revealed its agreement to purchase Iteris. This all-cash transaction, valued at approximately $335 million, provided shareholders with a substantial premium. They received $7.20 for each share they held, representing a significant 68% increase over the stock’s closing price from the day before the acquisition was announced.
Following successful shareholder approval on October 23, 2024, the deal was finalized. Since the delisting on November 1, 2024, Iteris shares have no longer been available for public trading on the NASDAQ or any other exchange.
Should investors sell immediately? Or is it worth buying Iteris?
Navigating Outdated Financial Information
A notable concern for investors is the persistence of obsolete data across numerous financial platforms. These sites continue to display outdated price charts and, in some cases, even future projections for the delisted security. As recently as October 3, 2025, MarketBeat issued a specific warning regarding potentially delisted stocks. For clarity, Investing.com confirms that Iteris has been operating as a wholly-owned subsidiary of Almaviva since November 2024.
Despite the change in corporate ownership, Iteris continues its business operations under the established leadership of CEO Joe Bergera. The company remains dedicated to its ClearMobility® platform, now benefiting from the international backing and resources of its new parent company.
Implications for Former Shareholders
For traders and investors, this development marks a definitive conclusion. There will be no further quarterly earnings reports, no new analyst coverage, and no share price fluctuations to track. Anyone interested in the future trajectory of the company’s underlying business must now follow the corporate communications and disclosures from Almaviva S.p.A. The era of the Iteris stock has reached its end.
Ad
Iteris Stock: Buy or Sell?! New Iteris Analysis from February 7 delivers the answer:
The latest Iteris figures speak for themselves: Urgent action needed for Iteris investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.
Iteris: Buy or sell? Read more here...
